MLchartDataset catalogue

BiTE

Term · Oncology and biomedicine · MLC-T-ONC-001092

A substance made in the laboratory that can bind to two target proteins on the surface of different cells. For example, a BiTE may bind to a certain protein on healthy T cells (a type of immune cell) and, at the same time, to a different protein on cancer cells. This brings the T cells and cancer cells close together so the T cells can more effectively kill the cancer cells. Some BiTEs are being used to treat certain types of cancer, including acute lymphoblastic leukemia, multiple myeloma, lymphoma, and small cell lung cancer. They are a type of targeted therapy. Also called bispecific T-cell engager.

Table 1. Record
IdentifierMLC-T-ONC-001092
FieldOncology and biomedicine
Expansionsbispecific T-cell engager
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-001092",
  "term": "BiTE",
  "field": "Oncology and biomedicine",
  "definition": "A substance made in the laboratory that can bind to two target proteins on the surface of different cells. For example, a BiTE may bind to a certain protein on healthy T cells (a type of immune cell) and, at the same time, to a different protein on cancer cells. This brings the T cells and cancer cells close together so the T cells can more effectively kill the cancer cells. Some BiTEs are being used to treat certain types of cancer, including acute lymphoblastic leukemia, multiple myeloma, lymphoma, and small cell lung cancer. They are a type of targeted therapy. Also called bispecific T-cell engager.",
  "expansions": [
    "bispecific T-cell engager"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/bite/"
}

Record 3,630 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.